Table 3 ICEP patient treatment and evolution
From: Idiopathic eosinophilic pneumonia in children: the French experience
Patient | Treatment | Evolution | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Initial treatment | Duration (months) | Response | Total length of follow-up (years) | Relapse (number) | Delay after the end of the initial regimen (years) | Maintenance oral CS | Clinical evolution | Last CT scan | Last spirometry | |
1 | oral CS § 1 mg/kg/day | 4 | Total | 1.5 | 0 | _ | _ | _ | m9: normal (1 nodule) | D |
2 | oral CS § 2 mg/kg/day | 2 | Total | 5.9 | 0 | _ | _ | asthma | m1: mild bronchiectasis | pO |
3 | oral CS * 1 mg/kg/day | 4 | Partial | 8.1 | 2 | 0.8 | 0.07 mg/kg/day | asthma | y7: interstitial opacities and cysts | R, pO |
4 | cyclosporine 5 mg/kg/day | 39 | Total | 3.2 | 0 | _ | _ | asthma | y3: normal | mild R (obesity) |
5 | 9 IV pulse + oral CS § 2 mg/kg/day | 12 | Partial | 7.2 | 1 | 6.1 | _ | asthma | y6: interstitial opacities and cysts | normal |